Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus (Q40726180)

23 September 2017

Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus (English)

1 reference

23 September 2017

0 references

Yasuto Akiyama

1

1 reference

23 September 2017

Kouji Maruyama

2

1 reference

23 September 2017

Tohru Mochizuki

3

1 reference

23 September 2017

Kazuki Sasaki

4

1 reference

23 September 2017

Yoichi Takaue

5

1 reference

23 September 2017

Ken Yamaguchi

6

1 reference

23 September 2017

1 August 2002

1 reference

23 September 2017

1 reference

23 September 2017

83

1 reference

23 September 2017

21-30

1 reference

23 September 2017

1

1 reference

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Human cytomegalovirus strain towne pp65 gene: Nucleotide sequence and expression in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

New coupling reagents in peptide chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900073-1

7 January 2021

10.1016/S0165-2478(02)00073-1

Identifiers

DOI

1 reference

release_h7f5al24hvachaioh4kq26sqse

23 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h7f5al24hvachaioh4kq26sqse

24 November 2022

mapped directly with Wikidata item

1 reference